课题基金 / 基金详情

Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)

Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
批准号:
10311624
负责人:
Amanda M Brandow
金额:
$54.8万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-08-31
关键词:
Abnormal HemoglobinsAccident and Emergency departmentAccountingAcuteAcute PainAdherenceAdoptionAffectAmerican Society of HematologyApplied ResearchCaringChildChild CareChronicClinicalCollaborationsDataDiseaseDissemination and ImplementationDoseEffectivenessEmergency CareEmergency MedicineEmergency department visitEngineeringErythrocytesFamilyFeedbackFoundationsFundingGoalsGrantGuideline AdherenceGuidelinesHealthHematological DiseaseHospitalizationInheritedInstitutesInstitutionInterventionInterviewJournalsMedicineModificationNational Heart, Lung, and Blood InstituteNew EnglandNursing ResearchOpioidOutcomePainPain managementPathway interactionsPatientsProtocols documentationQuality of CareQuality of lifeRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRecurrenceRegistriesReportingResearch MethodologySickle CellSickle Cell AnemiaSiteStressStructural RacismStructureTestingTheoretical Domains frameworkTimeUnited StatesUnited States National Academy of SciencesUniversitiesVisitVulnerable PopulationsWashingtonWorkanalytical methodbasecombatdata toolsdesigndissemination researcheffectiveness implementation studyeffectiveness implementation trialevidence baseevidence based guidelinesgroup interventionhospitalization ratesimplementation facilitationimplementation outcomesimplementation researchimplementation scienceimplementation strategyimprovedmultidisciplinarypain scorepediatric emergencysicklingtreatment adherencetreatment guidelinesvaso-occlusive crisisvaso-occlusive pain

项目摘要

项目成果

Amanda M Brandow的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Sickle cell disease (SCD) is an inherited blood disorder affecting approximately 36,000 children in the United States, approximately 90% of whom are Black. The disease is characterized by recurrent, severe pain crises which result in high rates of emergency department visits and hospitalizations, and decreased quality of life. The National Heart, Lung and Blood Institute, as well as the American Society of Hematology, have endorsed pain management guidelines regarding the timeliness of care for children presenting with these acute pain crises. These evidence based guidelines are infrequently followed, resulting in increased pain and hospitalizations. In additional to other barriers to following the guideline, structural racism has been proposed as a significant contributor and the New England Journal of Medicine recently called for the institution of SCD- specific pain management protocols to combat structural racism and reduce time to opioid administration. Our long-term goal is to improve the care and health outcomes of children with acute painful vaso-occlusive crisis treated in the emergency department. Our overall aim is to test a care pathway using multifaceted implementation strategies to increase guideline adherent care for children in the emergency department with acute painful vaso-occlusive crisis. Our primary aims are: 1) To compare the primary implementation outcomes of Reach, Adoption, and Implementation for the care pathway for treatment of children with acute painful vaso- occlusive crisis in the emergency department, between control and intervention groups and 2) To compare the primary clinical outcomes of guideline adherent care for opioid dose timing, hospitalization rates, and pain scores for the care pathway for the treatment of children with acute painful vaso-occlusive crises in the emergency department between control and intervention groups. We will test these aims using a randomized, multicenter stepped wedge design to conduct a type III hybrid effectiveness-implementation trial of the care pathway. Our proposal will institute the care pathway across seven emergency departments with the goal of improving guideline adherent care for children with SCD presenting with an acute pain crisis, thereby improving pain, decreasing hospitalizations and improving quality of life for this vulnerable population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Inflammatory Index as a Biomarker for Pain in Patients with Sickle Cell Disease
  • 批准号:
    10618737
  • 项目类别:
  • 资助金额:
    $69.61万
  • 财政年份:
    2019
  • 负责人:
    Amanda M Brandow
  • 依托单位:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
  • 批准号:
    9769125
  • 项目类别:
  • 资助金额:
    $75.68万
  • 财政年份:
    2018
  • 负责人:
    Amanda M Brandow
  • 依托单位:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
  • 批准号:
    10000989
  • 项目类别:
  • 资助金额:
    $74.88万
  • 财政年份:
    2018
  • 负责人:
    Amanda M Brandow
  • 依托单位:
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
  • 批准号:
    10462603
  • 项目类别:
  • 资助金额:
    $68.33万
  • 财政年份:
    2018
  • 负责人:
    Amanda M Brandow
  • 依托单位: